Advanced Search
Contact | Corporate | Help

Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar

Sponsors:
  • Dana-Farber Cancer Institute
  • Genentech
  • Beth Israel Deaconess Medical Center
  • Brigham and Women's Hospital
  • Women and Infants Hospital of Rhode Island
Phases:
  • Phase II
IndicationsAcronym:
  • Squamous Cell Carcinoma
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Erlotinib
Enrollment:
41

Additional information about NCT00476476.


SourceSolution © 2008-2012